Clinical Trial Details


Back to Clinical Trials Database

Phase II study of sunitinib (SU11248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a "sensitive" relapse.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 19-Feb-2009
Date Step1 close: 09-Jul-2010
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 48 - All Groups: 48
Treatment Sunitinib
Study Staff
Type of cancer
Participating groups EORTC Lung Cancer Group
Protocol summary
NCT number NCT00953459
EudraCT 2006-002485-19